“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Create an account and get access to all information about Protagonist Therapeutics
No Credit card required. Free Credit
No Credit card required. It’s fast, easy, and FREE! 🛠️
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
About
Protagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications
| C-Level 5 | VP - Level13 |
| Director22 | Manager17 |
| Others43 | |
| Structure | Email Format |
|---|---|
| <f>.<last>@ |
|
Protagonist Therapeutics looking to hire in Support in Newark, CA
Protagonist Therapeutics looking to hire in Testing in Newark, CA
Protagonist Therapeutics looking to hire in Embedded Design in Newark, CA
Collaborator
Essence
Expensify
Gcp
Nice cxone
Analytics
Ar
Assessment
Audit
Calibration
Stock Price & Market Cap: PTGX shares jumped to ~$89 (52-week high $93.25) after surging over 30% on October 10, 2025, valuing the company around $5.4
Read MoreInvesting.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that
Read MoreInvesting.com -- Protagonist Therapeutics (NASDAQ:PTGX) stock spiked 10% before being halted for volatility after The Wall Street Journal reported that
Read MoreReport reveals Johnson & Johnson is in talks to acquire Protagonist Therapeutics, building on an existing partnership for an oral immune disease drug.
Read MoreProtagonist Therapeutics is a clinical-stage biopharmaceutical company with a proprietary technology platform focused on discovering and developing peptide-based new chemical entities (NCEs) that can potentially transform existing treatment paradigms in disease areas with significant unmet medical needs. Our platform enables us to discover peptides in a de novo fashion with the desired degree of potency, specificity and selectivity, and also engineer oral stability with specific peptidomimetic and chemical modifications
Protagonist therapeutics operates in the Biotechnology industry.
Protagonist therapeutics's revenue is $434.43m
Protagonist therapeutics has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.